Therapeutic Effects of ADU-S100 as STING Agonist and CpG ODN1826 as TLR9 Agonist in CT-26 Model of Colon Carcinoma

Therapeutic Effects of ADU-S100 as STING Agonist and CpG ODN1826 as TLR9 Agonist in CT-26 Model of Colon Carcinoma

Cancer immunotherapy emerged as a novel therapeutic approach to destroy tumor cells, and it has grown toward clinical transition following successful fundamental research and clinical trials. Immunotherapy by efficacious adjuvants is critical for increasing protective immune responses against infect...

Full description

Bibliographic Details
Main Authors: Sare Hajiabadi, Soodeh Alidadi, Mohammad Mehdi Ghahramani Senoo, Zohreh Montakhab Farahi, Hamid Reza Farzin, Alireza Haghparast
Format: Article
Language:English
Published: Ferdowsi University of Mashhad 2023-07-01
Series:The Iranian Journal of Veterinary Science and Technology
Subjects:
sting agonist
tlr9 agonist
synergistic effect
immunotherapy
colon carcinoma model
Online Access:https://ijvst.um.ac.ir/article_43739_ee37165f908098a622ae2a7b17e2d30f.pdf

Similar Items

Similar Items